| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |